Literature DB >> 3944480

Immune response to Campylobacter jejuni in a rural community in Thailand.

M J Blaser, D N Taylor, P Echeverria.   

Abstract

We studied the prevalence of antibodies to Campylobacter jejuni in serum from healthy Thai villagers by using enzyme-linked immunosorbent assays with C. jejuni surface proteins as antigens. Levels of C. jejuni-specific IgA rose progressively through life, IgG peaked in the second year of life and then fell, and IgM peaked during late childhood and the teenage years. These findings confirm results observed in Bangladeshi children, and they suggest there is intense early exposure and continued exposure through life. The ratio of C. jejuni-specific IgA to total IgA was constant in all age groups while the ratio of specific IgG and IgM followed the same age-related pattern as the levels of antibody to C. jejuni. The age-related discordance between the C. jejuni-specific IgA and IgG levels observed in this and the previous study are at present unexplained.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944480     DOI: 10.1093/infdis/153.2.249

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Immunoglobulin KM genes in Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Christian A Vedeler
Journal:  Neurogenetics       Date:  2003-02-11       Impact factor: 2.660

2.  Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey.

Authors:  C K Porter; H El Mohammady; S Baqar; D M Rockabrand; S D Putnam; D R Tribble; M S Riddle; R W Frenck; P Rozmajzl; E Kilbane; A Fox; R Ruck; M Lim; Y J Johnston; E Murphy; J W Sanders
Journal:  Clin Vaccine Immunol       Date:  2008-10-08

Review 3.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

5.  Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation.

Authors:  D H Burr; M B Caldwell; A L Bourgeois; H R Morgan; R Wistar; R I Walker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Experimental Campylobacter jejuni infection in Macaca nemestrina.

Authors:  R G Russell; M J Blaser; J I Sarmiento; J Fox
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis.

Authors:  F O Mascart-Lemone; J R Duchateau; J Oosterom; J P Butzler; D L Delacroix
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

Review 9.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Serum antibodies to Giardia lamblia by age in populations in Colorado and Thailand.

Authors:  E N Janoff; D N Taylor; P Echeverria; M P Glode; M J Blaser
Journal:  West J Med       Date:  1990-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.